Mutations in BRCA1 do not appear to contribute significantly to the risk of prostate cancer progression, according to DNA ...
Merck & Co. has won U.S. Food and Drug Administration priority review for its application seeking expanded use of its blockbuster cancer drug Keytruda in certain patients with head and neck cancer.
LOS ANGELES, CA / ACCESS Newswire / February 24, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of ...
Eli Lilly and Company, Johnson & Johnson, Pfizer, Merck & Co., Inc., and Novo Nordisk A/S are the five Pharmaceutical stocks to watch today, according to MarketBeat’s stock screener tool. These ...
Merck Life Science opens formulation & technology centre in Turbhe, Navi Mumbai: Our Bureau, Bengaluru Tuesday, February 25, ...
The partners will test Summit’s ivonescimab alongside Pfizer’s antibody-drug conjugates in hopes of finding “potentially ...
Detailed results presented at a medical congress help reinforce analyst expectations the drug, called duvakitug, will be competitive with other Crohn’s, colitis medicines in testing.
Ligand originated, structured, and invested $50 million and led a syndicate of co-investors who invested $25 million in ...
Excerpts from recent editorials in the United States and abroad: ___ Feb. 20 The Washington Post says Musk's mass firings are backfiring President Donald Trump and Elon Musk have been rapidly firing ...
23h
Hosted on MSNShould You Buy VKTX Stock Amid Renewed M&A Speculations?Shares of Viking Therapeutics VKTX rose nearly 8% on Friday after several third-party reports suggested that it was being ...
A new clinical trial from Scripps Research in La Jolla aims to make significant gains in the global fight against malaria by ...
A meeting held between President Donald Trump and top pharmaceutical executives showed some tensions over drug pricing policy, tariffs and manufacturing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results